RRML - The grade of neoangiogenesis and the bone marrow blast count predict leukemic transformation-free survival in myelodysplastic syndromes
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- June 2024 -
 
The evaluation of a diagnostic... 10
A comprehensive review of Prof... 9
Assessment of ocrelizumab impa... 7
Romanian Review of Laboratory ... 6
Monitoring the sensitivity of ... 6
Challenges in prophylactic the... 6
Diagnostic value of stress myo... 6
Effect of Systemic Inflammator... 5
Evaluation of routine laborato... 4
The role of nitro oxidative fa... 4

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 24(2)/2016 DOI:10.1515/rrlm-2016-0020
XML
TXT

Letter to the editor

The grade of neoangiogenesis and the bone marrow blast count predict leukemic transformation-free survival in myelodysplastic syndromes

Emőke Horváth, Csilla Finna, Smaranda Demian, Előd-Ernő Nagy

Correspondence should be addressed to: Előd-Ernő Nagy

Abstract:

This is a Letter to Editor, therefore no abstract is included.

Received: 17.1.2016
Accepted: 19.4.2016
Published: 31.5.2016

 
  PDF Download full text PDF
(280 KB)
     
 
How to cite
Horváth E, Finna C, Demian S, Nagy EE. The grade of neoangiogenesis and the bone marrow blast count predict leukemic transformation-free survival in myelodysplastic syndromes. Rev Romana Med Lab. 2016;24(2):228-31. DOI:10.1515/rrlm-2016-0020